The European Commission called on the United States and other major COVID-19 vaccine producers Friday to export what they make, as the European Union does, rather than talk about waiving intellectual property (IP) rights to the shots.
Commission head Ursula von der Leyen told a news conference on the sidelines of a summit of EU leaders that discussions about the waiver would not produce a single dose of COVID-19 vaccine in the short and medium term.
"We should be open to lead this discussion. But when we lead this discussion, there needs to be a 360-degree view on it because we need vaccines now for the whole world," she said.
"The European Union is the only continental or democratic region of this world that is exporting at large scale," von der Leyen said.
She said about 50% of European-produced coronavirus vaccine is exported to almost 90 countries, including those in the World Health Organization-backed COVAX program, whose aim is to supply vaccines to mainly poor countries.
"And we invite all those who engage in the debate of a waiver for IP rights also to join us to commit to be willing to export a large share of what is being produced in that region," she said.
Only higher production, removing export barriers and the sharing of already-ordered vaccines could immediately help fight the pandemic quickly, she said.
"So what is necessary in the short term and the medium term: First of all, vaccine sharing. Secondly, export of vaccines that are being produced. And the third is investment in the increasing of the capacity to manufacture vaccines," she said.
Von der Leyen said the European Union had started its vaccine sharing mechanism, citing delivery of 615,000 doses to the Western Balkans as an example.